Balchem Co. (NASDAQ:BCPC) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 370,912 shares of the basic materials company's stock after purchasing an additional 8,942 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.14% of Balchem worth $60,457,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Westside Investment Management Inc. purchased a new position in shares of Balchem during the 3rd quarter worth about $27,000. R Squared Ltd purchased a new position in shares of Balchem during the 4th quarter worth about $29,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Balchem during the 3rd quarter worth about $35,000. Venturi Wealth Management LLC purchased a new position in shares of Balchem during the 4th quarter worth about $95,000. Finally, Smartleaf Asset Management LLC boosted its stake in shares of Balchem by 230.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock worth $106,000 after purchasing an additional 450 shares during the period. 87.91% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on BCPC shares. StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Sidoti upgraded shares of Balchem to a "hold" rating in a report on Tuesday, February 25th. Finally, HC Wainwright reiterated a "buy" rating and set a $190.00 price objective on shares of Balchem in a report on Monday, February 24th.

Remove Ads

Balchem Stock Up 0.7 %

Shares of NASDAQ:BCPC traded up $1.22 during trading hours on Friday, hitting $167.72. The company's stock had a trading volume of 87,531 shares, compared to its average volume of 138,421. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The company has a market capitalization of $5.46 billion, a price-to-earnings ratio of 42.68, a P/E/G ratio of 4.41 and a beta of 0.63. The firm's fifty day moving average price is $163.84 and its 200 day moving average price is $169.74.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The business had revenue of $240.00 million during the quarter, compared to the consensus estimate of $239.96 million. As a group, research analysts expect that Balchem Co. will post 4.64 EPS for the current year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.